Inhibition of lipolytic processes in rat adipose tissue by antimalaria drugs.
D000273:Adipose Tissue / Q000187:drug effects / Q000378:metabolism*; D000818:Animals; D000962:Antimalarials / Q000494:pharmacology*; D002738:Chloroquine / Q000494:pharmacology; D004822:Epididymis; D005227:Fatty Acids / Q000378:metabolism; D006493:Heparin / Q000494:pharmacology; D006886:Hydroxychloroquine / Q000494:pharmacology; D050356:Lipid Metabolism; D008297:Male; D011319:Primaquine / Q000494:pharmacology; D011796:Quinacrine / Q000494:pharmacology; D011802:Quinidine / Q000494:pharmacology; D011803:Quinine / Q000494:pharmacology; D051381:Rats
D000962:Antimalarials; D005227:Fatty Acids; D006886:Hydroxychloroquine; D002738:Chloroquine; D006493:Heparin; D011803:Quinine; D011796:Quinacrine; D011802:Quinidine; D011319:Primaquine